The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation
Acquisitions have the potential to add at least $1 billion in sales by 2028
Honan will lead the company in identifying and executing acquisitions that complement Emmes’ existing strong federal government client base, expand its biopharma portfolio, enhance its technology offerings, and broaden its global reach
The collaboration with IIT Kanpur will build on this foundation and expand the domain of research and development in healthcare technology
Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research
To create leading company developing medicines targeting metalloenzymes
Quantori develops solutions on the Databricks Lakehouse Platform providing real-time insights
Triazolam tablets are used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep)
Having a healthy gut is key as it permits the body to build a stronger immune system
Subscribe To Our Newsletter & Stay Updated
